A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

Solifenacin

Patients with residual OAB symptoms (urge urinary incontinence, urgency, and frequency) after treatment with other antimuscarinics

Trial Locations (60)

Unknown

Site CZ42003 Private Practice, Benešov

Site CZ42001 Private Practice, Beroun

Site CZ42014 Private Practice, Blansko

Site CZ42023 Private Practice, Boskovice

Site CZ42032 Private Practice, Brno

Site CZ42034 Hospital, Brno

Site CZ42035 Private Practice, Brno

Site CZ42036 Private Practice, Brno

Site CZ42038 Private Practice, Brno

Site CZ42039 Private Practice, Brno

Site CZ42058 Hospital, Brno

Site CZ42059 Hospital, Brno

Site CZ42025 Private Practice, Cheb

Site CZ42048 Private Practice, Dvůr Králové

Site CZ42040 Private Practice, Havlíčkův Brod

Site CZ42015 Private Practice, Hodonín

Site CZ42045 Private Practice, Hradec Králové

Site CZ42051 Private Practice, Jičín

Site CZ42027 Private Practice, Jindřichŭv Hradec

Site CZ42029 Private Practice, Jindřichŭv Hradec

Site CZ42026 Private Practice, Karlovy Vary

Site CZ42028 Private Practice, Karlovy Vary

Site CZ42030 Private Practice, Klatovy

Site CZ42049 Private Practice, Litoměřice

Site CZ42021 Private Practice, Litovel

Site CZ42050 Private Practice, Most

Site CZ42054 Private Practice, Ostrava

Site CZ42055 Private Practice, Ostrava

Site CZ42056 Private Practice, Ostrava

Site CZ42057 Private Practice, Ostrava

Site CZ42005 Private Practice, Pardubice

Site CZ42008 Private Practice, Pardubice

Site CZ42024 Private Practice, Pilsen

Site CZ42002 Private Practice, Prague

Site CZ42004 Private Practice, Prague

Site CZ42006 Private Practice, Prague

Site CZ42007 Private Practice, Prague

Site CZ42009 Private Practice, Prague

Site CZ42010 Private Practice, Prague

Site CZ42011 Private Practice, Prague

Site CZ42060 Private Practice, Prague

Site CZ42044 Private Practice, Roudnice nad Labem

Site CZ42031 Private Practice, Strakonice

Site CZ42020 Private Practice, Svitavy

Site CZ42047 Private Practice, Teplice

Site CZ42053 Private Practice, Teplice

Site CZ42042 Private Practice, Trutnov

Site CZ42052 Private Practice, Turnov

Site CZ42018 Hospital, Uherské Hradiště

Site CZ42019 Private Practice, Uherské Hradiště

Site CZ42043 Private Practice, Ústí nad Labem

Site CZ42046 Private Practice, Ústí nad Labem

Site CZ42041 Hospital, Velké Meziříčí

Site CZ42016 Private Practice, Vsetín

Site CZ42017 Private Practice, Vsetín

Site CZ42012 Private Practice, Zlín

Site CZ42013 Private Practice, Zlín

Site CZ42022 Private Practice, Zlín

Site CZ42033 Private Practice, Znojmo

Site CZ42037 Hospital, Znojmo

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT02087098 - A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics | Biotech Hunter | Biotech Hunter